Impact Factor
3.67
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.63
1,026 total citations
h5-index
37
h5 depth signal
Cited share
77.3%
231 of 299
Total citations
1,026
Citation footprint
Metric signal
3.12
External metric anchor
Self-citation
3.5%
36 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
431
Canada
122
Australia
42
Brazil
41
United Kingdom
31
Citing Fields of Research
Substance Abuse
666
Phytochemicals
43
Immunology
32
Neurosciences
28
Anesthetic & Pain Medicine
27
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
770
Articles tracked across the journal lifetime
Indexed publication set
299
231 cited publications
Last 12 months
64
5.3 publications/month
Open access share
3.1%
2 OA publications in the last year
Leading citing country
United States
431 citing publications
Leading citing field
Substance Abuse
666 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v6n1, Feb. 2021-
v1n1, 2016-
Active Coverage
Research Focus & Classification
Indexed Subjects
Substance Abuse
Issuing & Sponsoring Bodies
issuing body
International Cannabinoid Research Society
issuing body
International Association for Cannabinoid Medicines
Broad Categories
Pharmacology
Psychopharmacology
Substance Abuse
MeSH Descriptors
Cannabinoids
Cannabis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/25785125261497797
Open DOI
Sex-Related Differences in Medical Cannabis Use: A Nationwide Database Study
Introduction: With the increasing use of medical cannabis (MC) worldwide, understanding potential sex-related differences in treatment patterns and outcomes has become increasingly important. The objective of this study was to characteri...
02
DOI 10.1177/25785125261493188
Open DOI
Impact of Cannabis (Marijuana) on Nicotine Metabolism in U.S. Adults Who Smoke Cigarettes: Findings from NHANES 2013–2018
Background: A pharmacologic approach for smoking cessation is enzyme inhibition. Cytochrome P450 2A6 (CYP2A6)–mediated nicotine metabolism is a key target, yet no safe or effective inhibitors are currently available. We examined associat...
03
DOI 10.1177/25785125261497796
Open DOI
Prenatal Cannabinoid Exposure Induces Sex-Specific Alterations in Fetal Growth and Placental Lipid Metabolism Gene Expression
Background: Prenatal cannabis use is becoming increasingly more commonplace. However, cannabis exposure is linked to adverse pregnancy outcomes, including gestational hypertension, preeclampsia, and preterm birth. The aim of this study w...
04
DOI 10.1177/25785125261493191
Open DOI
Advancing a Pre-Clinical Model of Full-Term Prenatal Exposure to Vaporized Δ9-Tetrahydrocannabinol
Introduction: Use of cannabinoid vape products during pregnancy is a major public health concern.
Δ
9-tetrahydrocannabinol (THC), the main psychoactive constituent in cannabis, is rapid...
05
DOI 10.1177/25785125261492385
Open DOI
Awareness and Use of Delta-8-THC Cannabis Products in the United States: Findings from National Surveys in 2021 and 2022
Introduction: While recreational marijuana remains illegal under federal law in the United States, “hemp-derived” products that contain less than ≤ 0.3% Delta-9-tetrahydrocannabinol (THC) were legalized in 2018. New classes of intoxicati...
06
DOI 10.1177/25785125261490165
Open DOI
Monoacylglycerol Lipase Inhibition by JZL184 Improves Neurological Outcomes and Survival after Cardiac Arrest via 2-AG-Mediated Restoration of Cerebral Microcirculation
Background: Improving long-term survival rates after cardiac arrest (CA) is an important clinical challenge. The endocannabinoid 2-arachidonoylglycerol (2-AG) exerts endogenous neuroprotective and anti-inflammatory effects; its hydrolysi...
07
DOI 10.1177/25785125261490003
Open DOI
Efficacy and Safety of Cannabinoid-Based Interventions for Low Back Pain and Migraine: A Systematic Review of Randomized Controlled Trials
Introduction: Low back pain, migraine, and other headache disorders are major contributors to disability, and interest in cannabinoid-based interventions has increased despite uncertainty regarding their indication-specific therapeutic v...
08
DOI 10.1177/25785125261490626
Open DOI
Cannabis Social Equity Programs and Their Unintended Consequences
Cannabis social equity programs have been implemented in many U.S. jurisdictions to address disparities associated with cannabis prohibition and expand participation in the legal cannabis market. While these initiatives reflect important...
09
DOI 10.1177/25785125261489482
Open DOI
THC Labeling Discrepancies Across Cannabis Flower Product Subtypes in a State-Legal Market
Introduction: High-concentration delta-9-tetrahydrocannabinol (THC) products, with limited research, are becoming accessible in a rapidly expanding cannabis market. There is concern about poor labeling accuracy for THC in recreationally ...
10
DOI 10.1177/25785125261490171
Open DOI
How Health Care Experiences Shape Marijuana Use Motivations and Perceptions Among U.S. Adults
Background: Cannabis use among U.S. adults has increased substantially alongside expanding legalization and shifting public perceptions regarding its risks and benefits. While prior studies have examined sociodemographic patterns of cann...
Bibliographical & Catalog Notes
Also issued in print.